CD8A and renal cell carcinoma: Furthermore, Xu et al. [112] found that ExVs derived from RCC cells stimulated CD8+T cells, and in combination with GM-CSF and IL-12, effectively facilitated cytotoxicity against autologous RCC [renal cell carcinoma] cells in vitro.